MEK inhibition for low-grade serous ovarian cancer: are we there yet? | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Commentary

MEK inhibition for low-grade serous ovarian cancer: are we there yet?

Online download statistics by month:

Online download statistics by month: November 2020 to March 2023

	Abstract	Full	Pdf
Nov 2020	0	10	4
Dec 2020	0	14	6
Jan 2021	0	13	3
Feb 2021	0	6	6
Mar 2021	0	6	5
Apr 2021	0	4	4
May 2021	0	4	3
Jun 2021	0	0	1
Jul 2021	0	4	1
Aug 2021	0	7	5
Sep 2021	0	4	4
Oct 2021	0	0	1
Nov 2021	0	5	0
Dec 2021	0	4	4
Jan 2022	0	1	0
Feb 2022	0	2	1
Mar 2022	0	4	2
May 2022	0	3	4
Jun 2022	0	0	1
Aug 2022	0	4	0
Sep 2022	0	2	1
Dec 2022	0	1	1
Mar 2023	0	2	3
Total	0	100	60